Gyno-Pevaryl (Econazole Nitrate)

Gyno-Pevaryl is indicated for the treatment of fungal infections of the vagina.

• Vulvovaginal candidiasis caused by Candida species.
• Superficial vaginal yeast infections confirmed by laboratory testing.
• Adjunct therapy for recurrent yeast infections when prescribed by a healthcare professional.
• Use in patients who require a topical antifungal with a low systemic absorption profile.
• Management of mild to moderate symptoms such as itching, burning, and discharge associated with vaginal candidiasis.

Possible adverse reactions to Gyno-Pevaryl have been reported, most of which are mild and reversible.

Common

• Local irritation or burning sensation.
• Itching or mild rash in the vaginal area.
• Increased vaginal discharge with a mild odor.
• Mild abdominal cramps.
• Headache.
• Temporary discoloration of the applicator.

Serious

• Allergic reaction such as rash, swelling, or hives.
• Severe vaginal inflammation or ulceration.
• Rare systemic hypersensitivity reactions (e.g., Stevens‑Johnson syndrome).

Before using Gyno-Pevaryl, certain safety considerations should be reviewed to minimize risk.

• Confirm diagnosis of candidiasis before initiating therapy.
• Avoid use if known hypersensitivity to econazole or other imidazoles.
• Do not use during active vaginal bleeding or menstruation unless directed by a clinician.
• Use only as a short‑term treatment; prolonged use may disrupt normal vaginal flora.
• Consult a healthcare provider if symptoms persist beyond the recommended course.
• Pregnant or breastfeeding individuals should discuss potential risks with a clinician.

Econazole nitrate may interact with other medications or substances applied vaginally.

Avoid

• Concurrent use of other topical antifungal agents (e.g., clotrimazole, miconazole) without medical guidance.
• Vaginal douches or spermicidal products that could alter drug absorption.

Use with caution

• Systemic azole antifungals (e.g., fluconazole) that may increase overall azole exposure.
• Hormonal contraceptives administered vaginally, as absorption changes are possible.
• Herbal vaginal suppositories or creams, pending safety data.